(1) A complete separation of myo-inositol 1,4,5-[4,5-32P]trisphosphate prepared from human erythrocytes, and myo-[2-3H]inositol 1,3,4-trisphosphate prepared from carbachol-stimulated rat parotid glands [Irvine, Letcher, Lander & Downes (1984) Biochem. J. 223,[237][238][239][240][241][242][243], was achieved by anion-exchange high-performance liquid chromatography. This separation technique was then used to study the metabolism of these two isomers of inositol trisphosphate in carbachol-stimulated rat parotid glands.
PtdInsP2 was this isomer; in control tissues it must be <5% of the total PtdInsP2 radiolabelled by myo-[2-3H]inositol. (7) These data indicate that, provided that inositol 1,4,5-trisphosphate is studied independently of inositol 1,3,4-trisphosphate, the former shows metabolic characteristics consistent with its proposed role as a second messenger for calcium mobilization. The metabolic profile of inositol 1,3,4-trisphosphate is entirely different, and its function and source remain unclear.
Stimulation of a wide range of tissues by many agonists causes a selective enhancement in inosi- Michell, 1975 ) including a stimulated phosphodiesteratic cleavage of PtdInsP2 to form the second messenger, diacylglycerol (Nishizuka, 1984) , and InsP3 (Michell et al., 1981; Berridge, 1984; Berridge & Irvine, 1984) . Berridge (1983) proposed that Ins(1,4,5)P3 is also a second messenger whose principal effect is calcium mobilization, and considerable experimental evidence in support of this proposal has been obtained (Streb et al., 1983; Berridge & Irvine, 1984) .
In order to demonstrate that this hypothesis applies to the mode of action of Ca2+-mobilizing Vol. 229 receptors in rat parotid glands, one necessary objective is to assess the rate and amount of Ins(1,4,5)P3 accumulation in the stimulated gland. Initial support for these proposals came from the demonstration that stimulation of muscarinic cholinergic, ax-adrenergic, or substance P receptors results in a substantial and rapid accumulation of 3H-labelled InsP3 in parotid gland preparations Downes & Wusteman, 1983; Aub & Putney, 1984) . The mode of action of these receptors is known to involve the mobilization of Ca2+ from a common intracellular pool (Putney, 1977 (Putney, , 1982 . In contrast, activation of parotid gland fl-adrenergic receptors involves the activation of adenylate cyclase without Ca2+ mobilization (Schramm & Selinger, 1977) and does not cause accumulation of inositol phosphates (Berridge et al., 1982) .
However, our present understanding is complicated by the discovery that in stimulated rat parotid glands there are two InsP3 isomers, Ins(l,4,5)P3 and Ins(l,3,4)P3 . Furthermore, the source and function of the novel inositol trisphosphate, Ins(l ,3,4)P3, are as yet unknown. A complete separation of these two InsP3 isomers, which could lead to a study of the metabolism of each of them in stimulated tissues, is therefore an essential first step in clarifying the picture, and it is to this aim that the present study was directed. Downes & Wusteman (1983) . The final incubations of prelabelled slices each contained 0.46-0.72mg of protein, the exact value varying from one preparation to another.
Preparation of samples br h.p.l.c.
Incubations were terminated by addition of trichloroacetic acid followed by washing with diethyl ether as described previously (Downes & Wusteman, 1983 
Separation of InsP3 isomers
This was initially achieved using [3H]InsP3 from rat parotid glands stimulated with carbachol for 15min (which is predominantly the 1,3,4 isomer; Irvine et al., 1984) , and Ins(1, [4,5-32P] )P3 from human erythrocytes . The chromatography column was a 0.46cm x 25cm Partisil SAX 10 high pressure anion exchange column (packed by Technicol, Stockport, Cheshire SKI 3HS, U.K.). In preliminary trials we used adenine nucleotide markers (adenine, AMP, ADP and ATP), and followed their elution by their absorption at 254nm; we tried in particular to avoid using phosphate in the eluting medium so that non-radiolabelled inositol phosphates could be analysed. In our hands however, really sharp peak profiles of nucleotides, in turn indicative of entire separation of the InsP3 isomers, were only achieved by including some phosphate in the eluting medium.
The final conditions of elution were as follows. Samples in water were loaded onto the column after routine spiking with AMP, ADP and ATP and approx. 300d.p.m. of Ins(l,[4,5-32P])P3. Water was then allowed to flow through for 6min at 1.25ml/min (and this flow rate was maintained throughout for elution). Then, over 24min a linear gradient was passed through the column, rising from water to 100% .OM-ammonium formate buffered to pH 3.7 with orthophosphoric acid (i.e.
Pi content approx. 0.5M). The formate/phosphate buffer was passed through for a further 5 min, and then over the following 2min the eluant was returned linearly to water. Finally, a further 10min of water elution was employed before the column was ready for the next injection.
Most samples of inositol phosphates from parotid glands were 2.0ml in volume. The routine spiking with nucleotides helped to ensure that each sample was behaving normally (by following the A,54), and the inclusion of Ins(1[4,5-32P])P3 ensured that the location of this compound was always unambiguous; there was no significant spill-over of 32P radioactivity into the 3H channel. Routinely, we collected 32 x 0.25min samples, starting 3min before ATP was eluted, and finishing 5min afterwards; Ins(1,3,4)P3 was eluted with, or very close to, ATP, and Ins(1,4,5)P3 was eluted shortly afterwards (see below). The 0.31 ml samples were diluted with 0.5 ml of water and 0.5 ml of methanol, and then Sml of scintillant was added.
Although this elution regime was specifically designed for analysis of InsP3 isomers and was routinely used for this, on some occasions we did measure other inositol phosphates by collecting 1 or 0.5 min samples throughout the gradient up until just before ATP was eluted, and then changed to 0.25 min samples. Elution times were found to vary slightly between different columns, but the overall pattern is reproducible; a typical separation is shown in Fig. 1 . In this sample there are negligible counts in GroPIns and GroPInsP2. These two were found to be eluted just before ADP and 2-3 ml before Ins(1,3,4)P3 respectively (marked on Fig.  1) ; the separation of GroPInsP from InsP2 is not very wide, and for a detailed study of these two a change in the gradient may be necessary.
Chemical degradation of inositides to inositol phosphates 3H-labelled lipids from parotid fragments (Downes & Wusteman, 1983 ) were deacylated exactly as described by Clarke & Dawson (1981) . The glycerol moiety was then removed essentially as described by Brown & Stewart (1966) , that is, by limited digestion with O.1 M-or O.OlM-periodate (trial and error with radioactive samples, or following the A260 with GroPInsP2 from ox brain, lead us to use 90 min at room temperature, which completely removed the glycerol from GroPInsP2 while leaving the InsP3 structure substantially intact). This was followed by quenching with ethylene glycol and removal of the remaining aldehyde from the 1-phosphate with 1',1' dimethylhydrazine (Brown & Stewart, 1966) . The dimethylhydrazine was removed by filtering through Dowex W50 beads, and finally the solution was neutralized with NH3 before being loaded on to the h.p.l.c. column. For the h.p.l.c. analysis of these samples, the collection of fractions from the column was started earlier than usual, so that any GroPInsP2 remaining after the periodate treatment was also collected. In this way we were able to check routinely that > 95% of the glycerol moiety had been removed. Vol. 229 exchange h.p.l.c. It is evident that there is a complete baseline separation of the two isomers, enabling us to study them independently of each other. In some Ins(1,4,5)P3 preparations we detected another 32P peak (5-10%) coincident with Ins(1,3,4)P3; this was not ATP, as we analysed two such batches of [32P]InsP3 by ionophoresis and their [32P]ATP content was 0.01%. This second peak is also not for the most part Ins(1,3,4)P3 because when it was isolated, desalted and analysed by ionophoresis at pH 3.6 (Dawson & Clarke, 1972) or pH9.0 (Clarke & Dawson, 1981) at least 80% of the radioactivity migrated faster than an internal marker of Ins(1,4,5)P3. Ins(l,3,4)P3 has an identical ionophoretic mobility to Ins(1,4,5)P3 in these two buffers . Some samples of Ins(1,4,5)P3 (such as the one used for the experiment in Fig. 2 ) contained no detectable second peak of 32P-labelled material. At present we have no explanation for the occasional and unpredictable appearance of this other compound.
Rates of appearance of inositol trisphosphates in parotid glands
The separation of the two isomers enabled us to study their relative rates of appearance in an extensive series of experiments using carbacholstimulated parotid glands. Fig. 3 Fig. 3 gave very similar quantitative data, but in two other experiments the radiolabelling was much lower. In these latter experiments the kinetics of Ins(1 ,3,4)P3 were similar to Fig. 3 , but insufficient radioactivity was present to study Ins(1,4,5)P3. The reason for this variation in tissue labelling is not known.
Within the first 1 min of stimulation the kinetics of the two inositol trisphosphates are clearly very different. In particular, at the earliest times examined Ins(1,4,5)P3 is predominant, and may be produced with no apparent time lag (within the resolution time of these experiments). Ins(1,4,5)P3 reaches its maximal level by about 15 s, and then it declines, although it remains above control levels at least up to 15 min. This marked peak of Ins(1,4,5)P3 production, followed by a trough and then a gradual rise, was reproducible over several experiments.
Ins(1,3,4)P3 follows a very different pattern. There is a clear and reproducible lag before any increase is detectable. Once its formation begins, its synthesis is very rapid, though we must emphasize that until we know more about where it comes from we cannot assume that it has the same specific radioactivity as Ins(1,4,5)P3, and so we cannot draw any firm conclusions about the absolute rate of synthesis of Ins(1,3,4)P3 relative to that of Ins(1,4,5)P3. Ins(1,3,4)P3 continues to rise after the first 1 min of stimulation and, as shown previously by total InsP3 measurements (Downes & Wusteman, 1983; Aub & Putney, 1984) reaches a steady state after about 15min. At this time it predominates by about 10-fold over Ins(1,4,5)P3 .
Disappearance of inositol trisphosphates
Previous experiments have attempted to examine the rate of catabolism of inositol phosphates in carbachol-stimulated parotid glands by blocking the activation with antagonists (Downes & Wusteman, 1983; Aub & Putney, 1984) . The existence of two InsP3 isomers clearly complicates the interpretation of these data, and Fig. 4 shows data from an experiment designed to repeat these receptorblocking experiments, but examining the disappearance of the two InsP3 isomers separately. It is apparent that whereas the decline of Ins(1,3,4)P3 is, not surprisingly, similar to that of total InsP3 in earlier experiments (Downes & Wusteman, 1983; Aub & Putney, 1984) , the proportional rate of disappearance of Ins(1,4,5)P3 is very much faster. The low level of counts in this isomer measured in the continuing presence of high levels of Ins(1,3,4)P3 is pushing the h.p.l.c. separation to its limit, and so exact quantification is difficult, but it is clear that Ins(1,4,5)P3 has returned to near control levels, probably within 2-3 min of receptor blocking. We emphasize that these experiments were designed to measure specifically the disappearance of Ins(1,4,5)P3, and the curve showing the decline of Ins(1,3,4)P3 is only approximate; more detailed kinetics on total InsP3 [which after the first 3min is entirely Ins(1,3,4)P3] can be found in Downes & Wusteman (1983) and in Aub & Putney (1984) . PtdInsP2 in parotid cells A possible source of Ins(1,3,4)P3 is Ptdlns(3,4)P2 , so in one experiment we looked for evidence for this lipid in parotid fragments labelled with [3H]inositol as in Downes & Wusteman (1983) , before or after 15 min stimulation with carbachol. In triplicate samples of control and stimulated glands we were Time after atropine addition (min) Fig. 4 . Disappearance of inositol trisphosphates following receptor blocking Parotid glands were radiolabelled and stimulated with carbachol for 15 min as described in the legend to Fig. 1 . Then lOpM-atropine was added (Downes & Wusteman, 1983 ) and samples were taken at timed intervals after that. unable to detect any Ptdlns(3,4)P2; that is, at least 95% of the InsP3 derived from PtdInsP2 (see the Materials and methods section) was Ins(1,4,5)P3. There may be very small amounts of radiolabelled PtdIns(3,4)P2 which we cannot detect because our samples contained insufficient radioactivity, especially after stimulation (which decreases PtdInsP2 levels), but from our data we can state with confidence that in these experiments at least 95% of the [3H]inositol-labelled PtdInsP2 in control tissue was PtdIns(4,5)P2-Discussion Ins(1,4,5)P3 as a second messenger in parotid gland
The results described here throw light on both of the isomers of InsP3 under consideration. Firstly, by removing Ins(1,3,4)P3 from the Ins(1,4,5)P3 we have been able to study unambiguously for the first time the latter isomer's metabolism in a stimulated tissue. Having done so, it is clear that its metabolism is entirely consistent with the proposed role as a second messenger (Berridge, 1983; Streb et al., 1983; Berridge & Irvine, 1984) Irvine, unpublished work) and the kinetics of Ins(1,4,5)P3 in the present experiments suggest that the metabolism of this compound in parotid gland is very similar to that in the blowfly salivary gland.
The rate of disappearance of Ins(1,4,5)P3 is also consistent with its proposed messenger role. The physiological responses of the parotid gland (such as rubidium efflux) which are believed to be mediated by Ca2+, return within 3-4min to control levels on blocking of the receptor (Poggioli & Putney, 1982) . Previous kinetic observations on the decline of InsP3 in parotid glands (Downes & Wusteman, 1983; Aub & Putney, 1984) appeared to be at odds with this, in that InsP3 took 15 or more minutes to return to control levels. The experiments in Fig. 4 show that the decline of Ins(1,4,5)P3 is more rapid, consistent with its proposed role in calcium mobilization. They also show that previous calculated rates of InsP2 formation and hydrolysis (Downes & Wusteman, 1983; Aub & Putney, 1984) are complicated by the different kinetics of disappearance of the two InsP3 isomers, and so the previous conclusion of these workers (that not all of the InsP2 could be derived from InsP3, and therefore that some phosphodiesteratic hydrolysis of PtdIns4P is occurring), must now be re-interpreted; this question remains open.
Source of Ins(1,3,4)P3 While the data above are consistent with the suggested role of Ins(1,4,5)P3 in cellular metabolism, they still leave open some essential questions about Ins(1,3,4)P3. Our inability to detect radioactive Ptdlns(3,4)P2 before stimulation (limit of unequivocal detection is 5%) is interesting in view of the rapid formation (after the initial lag) of Ins(1,3,4)P3 in stimulated glands. This result could imply that Ins(1,3,4)P3 is produced by isomerization of Ins(1,4,5)P3, but if that is so, then the isomerase can only be active some several seconds after stimulation (for example it might be activated by calcium).
An alternative suggestion is that Ptdlns(3,4)P2 is indeed the precursor of Ins(1,3,4)P3 but that it is only formed on stimulation (at the location of phosphodiesterase action), so that it is immediately hydrolysed. Several groups (De Chaffoy de Courcelles et al., 1984; Taylor et al., 1984; Halenda & Feinstein, 1984) have reported a phorbol esterstimulated rise in PtdlnsP and PtdInsP2 radiolabelling which they interpret as a probable protein kinase C-mediated stimulation of PtdIns kinase and PtdlnsP kinase (and possibly PtdIns synthetase), presumably by a phosphorylation of these enzymes. If those data represent in part either the activation of different enzymes or allosteric modification of inositide synthetases (so that their catalytic properties are altered), to form some PtdIns(3,4)P2, then the present results would be explained. At present the simplest suggestion for Ins(1,3,4)P3 formation in these glands is the stimulation of a PtdIns(4)P-3-kinase, but the other possibilities discussed above remain open.
Function of Ins(1,3,4)P3
The function of Ins(1,3,4)P3 remains unknown; the time lag before it appears, and its comparatively slow catabolism as discussed above, make it unlikely that it has anything to do with acute Ca2+ homeostasis in the cell, though the evidence for that is purely circumstantial. It may be physiologically inactive yet functional, because it could represent a form of desensitization of one branch of inositide messenger function [that using Ca2+ via Ins(1,4,5)P3] without altering the other branch (that using kinase C via diacylglycerol). If we assume similar specific radioactivities of the two InsP3 isomers, then the data in Figs. 3 and 4 suggest similar rates of production of the two isomers (once a steady state has been reached) and thus there may be a significant increase of the diacylglycerol-to-Ca2+ stoichiometry, caused by the production of Ins(1,3,4)P3.
An alternative to this hypothesis would be that Ins(1,3,4)P3 is a second messenger in its own right with intracellular targets distinct from Ins(1,4,5)P3 and diacylglycerol. Whichever of these is the correct explanation, the identification of both Ins(1,3,4)P3 and Ins(1,4,5)P3 in stimulated parotid glands provides another example of the considerably versatility of the inositol phospholipid-dependent receptor signalling system.
